Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries

Código QR

Nonalcoholic Fatty Liver Disease and Risk of Heart Failure Among Medicare Beneficiaries

Background Nonalcoholic fatty liver disease (NAFLD) and heart failure (HF) are increasing in prevalence. The independent association between NAFLD and downstream risk of HF and HF subtypes (HF with preserved ejection fraction and HF with reduced ejection fraction) is not well established. Methods an...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Marat Fudim, Lin Zhong, Kershaw V. Patel, Rohan Khera, Manal F. Abdelmalek, Anna Mae Diehl, Robert W. McGarrah, Jeroen Molinger, Cynthia A. Moylan, Vishal N. Rao, Kara Wegermann, Ian J. Neeland, Ethan A. Halm, Sandeep R. Das, Ambarish Pandey
Formato:	article
Lenguaje:	EN
Publicado:	Wiley 2021
Materias:	heart failure heart failure with preserved ejection fraction heart failure with reduced ejection fraction nonalcoholic fatty liver disease Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/0348b254322045d6b98f37ff6e5d05af
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

A study of association between heart failure with preserved ejection fraction with hypertension and diabetes mellitus
por: Swapan Sarkar, et al.
Publicado: (2021)

Current status on the therapeutic strategies for heart failure and diabetic cardiomyopathy
por: Amy Hyein Kim, et al.
Publicado: (2022)

A Universal New Definition of Heart Failure With Improved Ejection Fraction for Patients With Coronary Artery Disease
por: Haozhang Huang, et al.
Publicado: (2021)

Valor pronóstico de la hiperuricemia en la insuficiencia cardíaca crónica
por: Martínez S,Alejandro, et al.
Publicado: (2004)

Interatrial shunt devices for heart failure with normal ejection fraction: a technology update
por: Cuthbert JJ, et al.
Publicado: (2017)

Clinical Outcomes of Patients with Coronary Artery Diseases and Moderate Left Ventricular Dysfunction: Percutaneous Coronary Intervention versus Coronary Artery Bypass Graft Surgery
por: Wang S, et al.
Publicado: (2021)

Tricuspid insufficiency after cardiac-implantable electronic device placement
por: Nismat Javed, et al.
Publicado: (2021)

Blood Pressure and Safety Events With Vericiguat in the VICTORIA Trial
por: Carolyn S. P. Lam, et al.
Publicado: (2021)

Recent and Upcoming Drug Therapies for Pediatric Heart Failure
por: Karla L. Loss, et al.
Publicado: (2021)

Sacubitril-Valsartan, Clinical Benefits and Related Mechanisms of Action in Heart Failure With Reduced Ejection Fraction. A Review
por: Domingo Pascual-Figal, et al.
Publicado: (2021)

Readmissions, Death and Its Associated Predictors in Heart Failure With Preserved Versus Reduced Ejection Fraction
por: Wan Ting Tay, et al.
Publicado: (2021)

Factors associated with prolonged hospitalization, readmission, and death in elderly heart failure patients in western Romania
por: Gyalai-Korpos I, et al.
Publicado: (2015)

Systolic Blood Pressure and Outcome in Patients Admitted With Acute Heart Failure: An Analysis of Individual Patient Data From 4 Randomized Clinical Trials
por: Johannes Grand, et al.
Publicado: (2021)

Potential Mechanisms of SGLT2 Inhibitors for the Treatment of Heart Failure With Preserved Ejection Fraction
por: Steffen Pabel, et al.
Publicado: (2021)

Validation of the 2016 ASE/EACVI Guideline for Diastolic Dysfunction in Patients With Unexplained Dyspnea and a Preserved Left Ventricular Ejection Fraction
por: Arno A. van de Bovenkamp, et al.
Publicado: (2021)

Clinical course and outcomes of chronic heart failure with preserved left ventricular ejection fraction in concomitant overweight and obesity with comorbid atrial fibrillation
por: P. P. Bidzilya, et al.
Publicado: (2021)

Guideline Adherence of β-blocker Initiating Dose and its Consequence in Hospitalized Patients With Heart Failure With Reduced Ejection Fraction
por: Yiling Zhou, et al.
Publicado: (2021)

Causes and predictors of hospital readmissions in patients older than 65 years hospitalized for heart failure with preserved left ventricular ejection fraction in western Romania
por: Mavrea AM, et al.
Publicado: (2015)

Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
por: Dzhioeva O, et al.
Publicado: (2020)

The Effects of Hypertension Stages on N-Terminal-Pro Brain Natriuretic Peptide (NT-Pro-BNP) Level and Left Ventricular Ejection Fraction
por: Kati Sriwiyati, et al.
Publicado: (2019)

Reduced ejection fraction heart failure – new data from multicenter studies and national registries regarding general and elderly populations: hopes and disappointments
por: Crișan S, et al.
Publicado: (2018)

Faltering Under Pressure: Limitations to Noninvasive Diastolic Function Assessments
por: James P. MacNamara, et al.
Publicado: (2021)

Prevalence and Prognosis of HFimpEF Developed From Patients With Heart Failure With Reduced Ejection Fraction: Systematic Review and Meta-Analysis
por: Yibo He, et al.
Publicado: (2021)

Cardiac MRI Based Left Ventricular Global Function Index: Association with Disease Severity in Patients with ICD for Secondary Prevention
por: Andreas Leonhard Schober, et al.
Publicado: (2021)

Circulating Biomarkers and Cardiac Structure and Function in Rheumatoid Arthritis
por: Masatake Kobayashi, et al.
Publicado: (2021)

Body Mass Index: An Effective Predictor of Ejection Fraction Improvement in Heart Failure
por: Li-fang Ye, et al.
Publicado: (2021)

The Prognostic Value of Lung Ultrasound in Patients With Newly Diagnosed Heart Failure With Preserved Ejection Fraction in the Ambulatory Setting
por: Blanka Morvai-Illés, et al.
Publicado: (2021)

Comparison of Pharmacological Treatment Effects on Long-Time Outcomes in Heart Failure With Preserved Ejection Fraction: A Network Meta-analysis of Randomized Controlled Trials
por: Yaowang Lin, et al.
Publicado: (2021)

Features of heart failure with preserved ejection fraction (HFpEF) in diabetic patients with resistant hypertension
por: M. A. Manukyan, et al.
Publicado: (2021)

The Impact of Deep Y Descent on Hemodynamics in Patients With Heart Failure and Preserved Left Ventricular Systolic Function
por: Daisuke Harada, et al.
Publicado: (2021)

Deep Learning Predicts Heart Failure With Preserved, Mid-Range, and Reduced Left Ventricular Ejection Fraction From Patient Clinical Profiles
por: Mohanad Alkhodari, et al.
Publicado: (2021)

European journal of heart failure. journal of the Working Group on Heart Failure of the European Society of Cardiology.
Publicado: (2002)

Vagal Neuromodulation in Chronic Heart Failure With Reduced Ejection Fraction: A Systematic Review and Meta-Analysis
por: Lucas Bonacossa Sant'Anna, et al.
Publicado: (2021)

European journal of heart failure
Publicado: (1999)

Visual versus fully automated assessment of left ventricular ejection fraction
por: Rami Mahmood Abazid, et al.
Publicado: (2018)

Left ventricular assistant devices for end-stage heart failure: report of two cases
por: Pedemonte,Oneglio, et al.
Publicado: (2014)

Dapagliflozin in the treatment of patients with heart failure with reduced left ventricular ejection fraction – a practical approach
por: Jadwiga Nessler
Publicado: (2021)

Asistencia ventricular mecánica como puente al trasplante en pacientes en shock cardiogénico: Experiencia preliminar en Chile con ABIOMED BVS 5000®
por: Castro G,Pablo, et al.
Publicado: (2006)

Pacientes elegibles para las nuevas terapias de la insuficiencia cardíaca en un policlínico especializado
por: Rossel,Víctor, et al.
Publicado: (2019)

Disfunción miocárdica en la sepsis
por: ANDRESEN,MAX, et al.
Publicado: (2010)